How Many Units Is 20 mg of Tirzepatide? (Extended Compounded Dose)

A 20 mg dose of tirzepatide is 33% above the FDA-approved maximum of 15 mg per week for both Mounjaro and Zepbound. This dose was not studied in major Phase 3 clinical trials and has significantly limited long-term safety data. Some compounding pharmacies offer 20 mg as an extended off-label dose for patients who plateau on standard doses, but it requires direct physician supervision and frequent monitoring. Do not self-escalate to 20 mg without explicit physician direction. 

How many units is 20 mg of tirzepatide depends on your vial's concentration. At the 20 mg/ml concentration, 20 mg equals exactly 100 units, a full 1 ml insulin syringe. At 10 mg/ml, 20 mg equals 200 units (requires two separate draws). At 5 mg/ml, 20 mg equals 400 units (multiple draws). Note that 20 mg is 33% above the FDA-approved tirzepatide maximum of 15 mg per week and is not FDA-approved. Checkout this GLP-1 dose calculator for better insights.

Quick Answer Table: 20 mg Tirzepatide to Units

The 20 mg dose is an extended off-label compounded dose, used in some protocols for patients who plateau on 15 mg. It is not FDA-approved.

Here is what to know up front about 20 mg tirzepatide units. This is the tirzepatide highest dose commonly offered by compounding pharmacies. It is 33% above the FDA-approved maximum of 15 mg per week, per the FDA prescribing information. The 20 mg dose has not been studied in Phase 3 clinical trials for safety or efficacy. At 20 mg/ml concentration (the practical choice at this dose), 20 mg = 100 units (a full 1 ml syringe). For broader context, see compounded tirzepatide dosage.

The Math: How We Calculated This

The formula for compounded tirzepatide 20mg to units is:

Units = (mg dose ÷ concentration in mg/ml) × 100

Worked example at 20 mg/ml (practical for this dose):

20 mg ÷ 20 mg/ml = 1.0 ml 1.0 ml × 100 = 100 units (full 1 ml syringe)

At 10 mg/ml: 20 ÷ 10 = 2.0 ml = 200 units (requires two 1 ml syringe draws)

At 5 mg/ml: 20 ÷ 5 = 4.0 ml = 400 units (four separate draws, not practical)

The 20mg to units conversion is only practical at 20 mg/ml concentration. Patients on this off-label dose are almost always switched to 20 mg/ml vials.

Why 20 mg Significantly Exceeds the FDA-Approved Maximum

The FDA approved 15 mg as the maximum tirzepatide dose based on Phase 3 clinical trials. The 20 mg dose is:

• 33% higher than the FDA-approved maximum

• Not studied in major Phase 3 clinical trials

• Without established long-term safety data

• Used only in off-label compounded protocols

Risks at extended doses like 20 mg may include:

• Significantly increased nausea, vomiting, and diarrhea

• Higher risk of pancreatitis

• Higher risk of gallbladder issues (gallstones, cholecystitis)

• Higher risk of severe dehydration from prolonged GI symptoms

• Possible cardiovascular concerns not seen at approved doses

• Other unknown long-term effects

Patients prescribed 20 mg of tirzepatide require more frequent physician check-ins (typically every 4 to 8 weeks), regular blood work including kidney function, and prompt evaluation of any unusual symptoms. The dose is generally considered only after careful risk-benefit analysis by an experienced obesity medicine physician.

How to Draw 20 mg Tirzepatide

The 20 mg tirzepatide syringe choice depends entirely on concentration.

At 20 mg/ml (100 units): Use a 1 ml insulin syringe. Draw the full syringe to the 100 unit (1 ml) mark. This is the only practical concentration for the 20 mg dose. The full syringe leaves no room for air bubble correction, so careful drawing technique is essential.

At 10 mg/ml (200 units): Two-stage draw. Use two 1 ml insulin syringes. First syringe: 100 units, inject. Second syringe: 100 units, inject in a different site. Two injections the same day.

At 5 mg/ml (400 units): Multi-stage process with four 1 ml syringes. Not practical for routine weekly use.

For full guidance on syringe sizes, see how to read insulin syringe units.

When 20 mg May Be Considered

Off-label tirzepatide 20 mg dose is most commonly considered for:

• Patients who plateau on 15 mg without sufficient weight loss progress

• Patients with documented strong response at 15 mg seeking continued progress

• Patients in custom protocols designed by experienced obesity medicine physicians

The decision to use 20 mg of tirzepatide should involve careful documentation of:

• Time at 15 mg (typically 12 weeks or more before escalation)

• Tolerance to side effects at 15 mg

• Specific goals and clinical rationale

• Increased monitoring frequency

• Clear plan for de-escalation if needed

If your physician has prescribed 20 mg, expect more frequent visits and lab work than at standard doses.